Literature DB >> 7440315

Chronic chondritis of the equine arytenoid cartilage.

P F Haynes, T G Snider, J R McClure, J J McClure.   

Abstract

Chronic chondritis of the arytenoid cartilage was diagnosed in 7 male Thoroughbred horses examined for obstructive upper airway disorders. The history of the cases was characterized by a 3- to 6-month progression of exercise intolerance and inspiratory dyspnea during exercise. Endoscopy revealed marked asymmetry of the rima glottidis, partial or complete inability to abduct the involved cartilage, and axial displacement of the involved arytenoid cartilage. In less severe cases, the disorder was confused with laryngeal hemiplegia. Focal elevated lesions of the involved cartilage, which were frequently seen, produced contact lesions on the contralateral cartilage. Subtotal arytenoidectomy was performed in 6 cases. Histologic examination of the removed cartilages revealed marked lamination of the cartilage with fibrous connective tissue. Granulating sinus tracts were seen in 3 cases. The surgical intervention resulted in marked improvement of exercise intolerance in 5 cases.

Entities:  

Mesh:

Year:  1980        PMID: 7440315

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Flock health survey of Irish Texel society breeders and larynx examination in Texel sheep.

Authors:  Aideen Kennedy; Séamus Fagan; Colm Brady; John Fagan; Eamon Wall; Seamus Hoey; Emma Tobin; Mícheál Casey; Maresa Sheehan
Journal:  Ir Vet J       Date:  2020-08-07       Impact factor: 2.146

2.  Septic epiglottic chondritis with abscessation in 2 young Thoroughbred racehorses.

Authors:  Tomas Infernuso; Ashlee E Watts; Norm G Ducharme
Journal:  Can Vet J       Date:  2006-10       Impact factor: 1.008

3.  Computed tomography-guided tissue engineering of upper airway cartilage.

Authors:  Bryan N Brown; Nicholas J Siebenlist; Jonathan Cheetham; Norm G Ducharme; Jeremy J Rawlinson; Lawrence J Bonassar
Journal:  Tissue Eng Part C Methods       Date:  2013-12-11       Impact factor: 3.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.